Objective: To compare the Medicare Part D market share of brand drugs with their net-to-list price ratio.
Data Sources And Study Setting: SSR Health Brand Net Price Tool and Medical Expenditure Panel Survey, 2007-2019.
Study Design: For each drug, we calculated the ratio of net to list price and the percent of users that were Medicare-eligible.
Background: The COVID-19 pandemic led to large-scale cancellation and deferral of elective surgeries. We quantified volume declines, and subsequent recoveries, across all hospitals in Maryland.
Materials And Methods: Data on elective inpatient surgical volumes were assembled from the Maryland Health Service Cost Review Commission for years 2019-2020.
This study compares revenue of Maryland hospitals in March-July 2020 vs historical trends and assesses whether rate increases for inpatient and outpatient services that were permitted to offset pandemic-related decines in revenues were associated with changes to state hospital revenue.
View Article and Find Full Text PDF